Generic Medicine Pharmaceutical Companies Presentation 
Express Pharma
JANUARY 25, 2025
The Indian pharmaceutical sector is loaded with talent and has made great strides in generic medicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries. In Conclusion, the Union Budget 2025-26 presents a key opportunity to boost Indias pharmaceutical sector.
Express Pharma
AUGUST 30, 2023
Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MARCH 14, 2023
The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects. He has been advising pharmaceutical companies and healthcare providers for a number of years.
Express Pharma
APRIL 16, 2024
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most.
Express Pharma
MAY 10, 2024
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. Such partnerships are particularly valuable in addressing the healthcare needs of low- and middle-income countries.
pharmaphorum
MAY 26, 2022
Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
European Pharmaceutical Review
FEBRUARY 20, 2025
The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.
Expert insights. Personalized for you.
76 
Let's personalize your content